Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | AZN | AMGN | GILD | GSK |
| Company | Akcea Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 18.15 | 202.55 | 346.18 | 138.26 | 58.96 |
| High | 18.17 | 204.61 | 351.72 | 141.40 | 59.57 |
| Low | 18.13 | 202.07 | 345.41 | 137.60 | 58.14 |
| Latest | 18.17 | 204.75 | 350.95 | 140.46 | 59.19 |
| Change | +0.03 | +2.51 | +1.13 | +1.43 | +0.25 |
| % Change | +0.17% | +1.24% | +0.32% | +1.03% | +0.42% |
| Volume | 815,300 | 1,914,259 | 1,366,114 | 4,215,256 | 3,461,117 |
| 20-Day Average Volume | 661,490 | 1,866,826 | 2,746,443 | 5,938,668 | 4,224,048 |
| Previous Close | 18.14 | 202.24 | 349.82 | 139.03 | 58.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 194.98 | 350.29 | 139.26 | 55.17 |
| 20-Day Raw Stochastic | 70.59% | 87.35% | 45.65% | 48.52% | 95.45% |
| 20-Day Relative Strength | 73.10 | 58.73 | 46.80 | 48.85 | 63.55 |
| Weighted Alpha | -23.90 | +50.39 | +25.48 | +33.39 | +67.26 |
| Today's Opinion | 72% Buy | 88% Buy | 56% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 64% Buy | 88% Buy | 40% Buy | 40% Buy | 88% Buy |
| Last Month's Opinion | 8% Buy | 56% Buy | 88% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +1.66% since 04/07/26 | +3.07% since 04/07/26 | +0.94% since 04/07/26 | +6.03% since 04/07/26 |
| Low | 18.08 on 10/05/20 | 200.70 on 04/13/26 | 342.35 on 04/08/26 | 137.02 on 04/13/26 | 56.51 on 04/08/26 |
| High | 18.17 on 10/09/20 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.57 on 04/14/26 |
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | +7.50% since 03/13/26 | -4.30% since 03/13/26 | -3.37% since 03/13/26 | +10.89% since 03/13/26 |
| Low | 18.05 on 09/21/20 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 51.54 on 03/20/26 |
| High | 18.22 on 09/28/20 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 59.57 on 04/14/26 |
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | +5.95% since 01/14/26 | +6.53% since 01/14/26 | +12.93% since 01/14/26 | +16.57% since 01/14/26 |
| Low | 9.81 on 08/05/20 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 47.62 on 01/20/26 |
| High | 19.65 on 08/31/20 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | +19.92% since 10/14/25 | +19.26% since 10/14/25 | +18.26% since 10/14/25 | +34.10% since 10/14/25 |
| Low | 9.81 on 08/05/20 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.85 on 10/24/25 |
| High | 19.65 on 08/31/20 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 313,655,648 | 188,792,608 | 172,567,104 | 119,735,248 |
| Shares Outstanding, K | 101,599 | 1,550,908 | 539,685 | 1,241,222 | 2,031,477 |
| Annual Sales | 488,540,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | 40,770,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 22,380,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,424,970,000 |
| Last Quarter Net Income | -49,580,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 851,670,000 |
| 60-Month Beta | 1.45 | 0.35 | 0.47 | 0.39 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.68 on 02/04/26 |
| Latest Earnings Date | 11/03/20 | 05/05/26 | 04/30/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.470 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.27 | 16.07 | 17.05 | 12.88 |